Epidemiological studies have consistently shown that elevated levels of the inflammatory biomarker C-Reactive Protein (CRP) are associated with an increase in risk for developing cardiovascular disease, autoimmune and metabolic diseases, Alzheimer’s disease, and cancer [2–5]. The gene discussed is CRP; the disease is early-onset autosomal dominant Alzheimer disease.